169 related articles for article (PubMed ID: 27190997)
1. The Antitumor Effect of Gekko Sulfated Glycopeptide by Inhibiting bFGF-Induced Lymphangiogenesis.
Ding XL; Man YN; Hao J; Zhu CH; Liu C; Yang X; Wu XZ
Biomed Res Int; 2016; 2016():7396392. PubMed ID: 27190997
[TBL] [Abstract][Full Text] [Related]
2. Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factor.
Zhang SX; Zhu C; Ba Y; Chen D; Zhou XL; Cao R; Wang LP; Ren Y; Wu XZ
J Biol Chem; 2012 Apr; 287(16):13206-15. PubMed ID: 22371501
[TBL] [Abstract][Full Text] [Related]
3. Effects of Gekko sulfated polysaccharide-protein complex on human hepatoma SMMC-7721 cells: inhibition of proliferation and migration.
Chen D; Yao WJ; Zhang XL; Han XQ; Qu XY; Ka WB; Sun DG; Wu XZ; Wen ZY
J Ethnopharmacol; 2010 Feb; 127(3):702-8. PubMed ID: 19969061
[TBL] [Abstract][Full Text] [Related]
4. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
[TBL] [Abstract][Full Text] [Related]
5. Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells.
Yang Y; Gao Z; Ma Y; Teng H; Liu Z; Wei H; Lu Y; Cheng X; Hou L; Zou X
Oncotarget; 2016 Jun; 7(25):38025-38035. PubMed ID: 27203545
[TBL] [Abstract][Full Text] [Related]
6. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
8. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
9. 3-O-Acetyloleanolic acid inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis via suppression of angiopoietin-1/Tie-2 signaling.
Hwang-Bo J; Park JH; Chung IS
Phytother Res; 2020 Feb; 34(2):359-367. PubMed ID: 31680342
[TBL] [Abstract][Full Text] [Related]
10. MiR-19a enhances cell proliferation, migration, and invasiveness through enhancing lymphangiogenesis by targeting thrombospondin-1 in colorectal cancer.
Yin Q; Wang PP; Peng R; Zhou H
Biochem Cell Biol; 2019 Dec; 97(6):731-739. PubMed ID: 31199884
[TBL] [Abstract][Full Text] [Related]
11. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.
Ma C; Yin H; Zhong J; Zhang Y; Luo C; Che D; Fang Z; Li L; Qin S; Liang J; Qi W; Yang Z; Zhou T; Ma J; Yang X; Gao G
Int J Oncol; 2017 Jun; 50(6):2000-2010. PubMed ID: 28440474
[TBL] [Abstract][Full Text] [Related]
12. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Chen HM; Tsai CH; Hung WC
Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
14. Antitumor and Antimetastatic Activity of Synthetic Hydroxystilbenes Through Inhibition of Lymphangiogenesis and M2 Macrophage Differentiation of Tumor-associated Macrophages.
Kimura Y; Sumiyoshi M; Baba K
Anticancer Res; 2016 Jan; 36(1):137-48. PubMed ID: 26722037
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells.
Tzeng HE; Chang AC; Tsai CH; Wang SW; Tang CH
Oncotarget; 2016 Jun; 7(25):38566-38578. PubMed ID: 27229532
[TBL] [Abstract][Full Text] [Related]
16. The mineral dust-induced gene,
Zhou H; Geng F; Chen Y; Du J; Zhang X; Liu B; Song D; Hou H; Zhao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760153
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
Lin T; Gong L
Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
[TBL] [Abstract][Full Text] [Related]
18. Recombinant snake venom cystatin inhibits tumor angiogenesis in vitro and in vivo associated with downregulation of VEGF-A165, Flt-1 and bFGF.
Xie Q; Tang N; Wan R; Qi Y; Lin X; Lin J
Anticancer Agents Med Chem; 2013 May; 13(4):663-71. PubMed ID: 23094915
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol Prevents Tumor Growth and Metastasis by Inhibiting Lymphangiogenesis and M2 Macrophage Activation and Differentiation in Tumor-associated Macrophages.
Kimura Y; Sumiyoshi M
Nutr Cancer; 2016; 68(4):667-78. PubMed ID: 27145432
[TBL] [Abstract][Full Text] [Related]
20. [Endostar reduces the growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer].
Jia YT; Li ZX; Liu M; Chen SA; Zhang L; Wang YD
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):254-7. PubMed ID: 19615276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
